Funding to attract and advance Canadian clinical research in inflammatory bowel disease TORONTO, ON – Takeda Canada Inc. (Takeda) is pleased to announce its support of the Canadian Inflammatory Bowel Disease… Read More
VANCOUVER, BC – SaNOtize Research & Development Corp., a therapeutics technology company based in Vancouver, BC, announced the start of a Phase 2 safety and efficacy trial of its novel… Read More
KIRKLAND, QC – Pfizer Canada announced that Health Canada has granted a Notice of Compliance with conditions (NOC/c) to ELREXFIO (elranatamab solution for injection). ELREXFIO is indicated for the treatment… Read More
VANCOUVER, BC – Acuitas Therapeutics, Inc. was recently named one of BC’s Top Employers of 2024. The Vancouver-based, privately held biotechnology firm is the global leader in the development of… Read More
Approval is based on the Phase 3 KEYNOTE-811 Trial KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted… Read More
